HemosIL RecombiPlasTin 2G
by Instrumentation Laboratory CO
510(k) K070005
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK070005 | Date15 Aug 2007 | StatusActive |
Official records
- FDA 510(k) database K070005
Recalls
-
- Terminated Z-1784-2013
Instrumentation Laboratory is recalling HemosIL RecombiPlasTin 2G (RPT2G), Part No. 0020009580 (8 mL Size) due to being Out of Specification.
Timeline
- Cleared FDA 510(k) K070005
- Recall initiated FDA recalls Z-1784-2013
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- GJS
- Device class
- Class II
- Regulation
- 21 CFR Part 864.7750
- Advisory committee
- Hematology
- FDA decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 6 Oct 2026
HemosIL RecombiPlasTin 2G is a prothrombin time test reagent used to measure the time required for the conversion of fibrinogen to fibrin. By adding tissue thromboplastin to patient plasma in the presence of calcium ions, the reagent initiates the activation of the extrinsic coagulation pathway.
This device is regulated under 21 CFR 864.7750 and has received FDA 510(k) clearance. The reagent is formulated to be insensitive to therapeutic levels of heparin.
Devices cleared under K070005
Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.
| UDI-DI | Size and differences | |||
|---|---|---|---|---|
| HemosIL RecombiPlasTin 2G (20 mL) 00020003050 | 00020003050 / 00020003050 | 08426950447627 | — | On the market |